key: cord-0001415-wzt9w46s
authors: Liggett, Stephen B.; Bochkov, Yury A.; Pappas, Tressa; Lemanske, Robert F.; Gern, James E.; Sengamalay, Naomi; Zhao, Xuechu; Su, Qi; Fraser, Claire M.; Palmenberg, Ann C.
title: Genome Sequences of Rhinovirus C Isolates from Wisconsin Pediatric Respiratory Studies
date: 2014-03-27
journal: Genome Announc
DOI: 10.1128/genomea.00203-14
sha: 484ae48794ff4ad21fe1886753c4a2cb76e60821
doc_id: 1415
cord_uid: wzt9w46s

Human rhinovirus (RV) isolates from the RV-C species are recently discovered infectious agents that are closely linked to asthma and wheezing etiologies in infants. Clinical study samples collected at the University of Wisconsin–Madison describe 41 nearly complete genome sequences representing 21 RV-C genotypes.

and RV-C species of the Enterovirus genus in the Picornaviridae family. A classic panel of 99 RV-A and RV-B species are the canonical agents of the common cold. A full set of RNA genome sequences for these historic types was completed in 2009 (1) . Although serotyping played an early role in RV taxonomy, current classification is based on sequence conservation (2) . Strains are assigned to common species if they share Ͼ70% amino acid identity in the P1, 2C, and 3CD regions. Isolates are further subdivided into numeric genotypes that respect the historic naming system, but now rely almost entirely on sequence comparisons of the VP1 or VP4/VP2 coding sequences. The preferred RV nomenclature designates the species letter (A, B, or C) and type number (e.g., A16). Strain designations are unique to each GenBank accession number. Assignment of a new strain to a known genotype requires Ͼ86 to 87% aligned nucleic acid identity in either or both of the key capsid-coding regions (2) .

The RV-C species were first discovered in 2006 as part of broad spectrum clinical surveillance studies (3) (4) (5) . While clearly rhinoviruses, they are not readily propagated in typical cell culture systems (6) so much of their biology is inferred from sequence comparisons. Currently, 51 genotypes (as binned by VP1 nucleotide identity) have been described (2) . These isolates are important because they are associated with up to half of RV infections in young children (6) . Within the context of virus surveillance, the University of Wisconsin hospitals and clinics in Madison, WI, are participating in several studies with the goal of determining how RV sequence variation is linked to cold symptoms and asthma exacerbations. The Childhood Origins of Asthma (COAST), Mechanisms and Environmental Determinants of Rhinovirus Illness Severity (RhinoGen), and T Regulatory Cells and Childhood Asthma (T-Reg) protocols collect and screen infant nasal secretions using multiplex PCR assays (7), rhinovirus PCR (8), or both. Between 1999 and 2010, hundreds of solitary RV infections were identified. Partial sequencing assigned these isolates to relevant species, but for some, particularly the RV-C species, the data suggested several potential new genotypes, or provided confirmation for similar reclassification proposals (9).

Multiple COAST and RhinoGen isolates were then reexamined using massively parallel sequencing techniques applied directly to clinical samples (10) . The single-pass methodology gave, on average, 93% genome coverage to a depth of 8 to 10 reads for 179 study-specific isolates. For the RV-C species, the technique resolved nearly full genomes for 41 isolates, representing 21 different genotypes (9) . Relative to prototype RV-C genomes, which average~7,097 bases (b) (1), most of these assemblies were missing the difficult-to-sequence 5= and/or 3= termini (average, ⌬ 465 b) and occasionally, short internal fragments (Ͻ100 b) for which the contigs were not be explicitly linked. Nevertheless, every new sequence (average, 6,592 b; median, 6,632 b) was unambiguously aligned with an index compilation of RV-C prototype sequences (2) . For C17, C22, C26, C28, C32, C36, C38, C41, C42, C43, C45, and C49, the new data include the first non-capsid descriptions of these genotypes.

Nucleotide sequence accession numbers. Each contiguous data set has been deposited at DDBJ/EMBL/GenBank using the accession numbers listed below. Each unit described here is the first genome version of the sequence of that isolate: CO2, JN815248, JN837695, JN990703, JQ245968, and JX025557; C03, JN798567, and JN990700; C04, JF781509; C06, JN815245, and JN990702; C07, JN798559, JN798570, JN837689, JQ994495, and JX025556; C08, JQ245964, and JQ245973; C15, JN837688; C17, JN815240, JN815244, and JQ837720; C22, JN621242; C25, JN837685; C26, JX193796; C28, JN798569; C32, JN798581, and JQ994498; C36, JN541267; C38, JN837691; C40, JF781505, JN815251, and JQ245963; C41, JN798565; C42, JQ994500; C43, JN815249, JN837687, and JX074056; C45, JN837686; C49, JF907574, JN798566, and JN798568.

Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution

Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types

Clinical features and complete genome characterization of distinct human rhinovirus genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children

Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections

MassTag polymerase-chainreaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during

Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C

High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses

A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants

Human rhinovirus species and season of infection determine illness severity

Genome sequences of rhinovirus A isolates from Wisconsin pediatric respiratory studies

This work was supported by National Institutes of Health Public Health Service grants: P01-HL70831 (COAST), U19-AI070503 (RhinoGen), R01-HL080072 (T-Reg), U19-AI104317 (to A.C.P.) and HL091490 (to S.B.L.). This project was also funded in part by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract HHSN272200900009C.